Scientific article
English

Chemoproteomics-Enabled Discovery of a Potent and Selective Inhibitor of the DNA Repair Protein MGMT

Published inAngewandte Chemie, vol. 55, no. 8, p. 2911-2915
Publication date2016
Abstract

We present a novel chemical scaffold for cysteine-reactive covalent inhibitors. Chloromethyl triazoles (CMTs) are readily accessed in only two chemical steps, thus enabling the rapid optimization of the pharmacological properties of these inhibitors. We demonstrate the tunability of the CMTs towards a specific biological target by synthesizing AA-CW236 as the first potent non-pseudosubstrate inhibitor of the O6-alkylguanine DNA methyltransferase (MGMT), a protein of major clinical significance for the treatment of several severe cancer forms. Using quantitative proteomics profiling techniques, we show that AA-CW236 exhibits a high degree of selectivity towards MGMT. Finally, we validate the effectiveness of our MGMT inhibitor in combination with the DNA alkylating drug temozolomide in breast and colon cancer cells by fluorescence imaging and a cell-viability assay. Our results may open a new avenue towards the development of a clinically approved MGMT inhibitor.

Keywords
  • Activity-based protein profiling
  • Drug discovery
  • Mass spectrometry
  • MGMT
  • Proteomics
Research groups
Citation (ISO format)
WANG, Chao et al. Chemoproteomics-Enabled Discovery of a Potent and Selective Inhibitor of the DNA Repair Protein MGMT. In: Angewandte Chemie, 2016, vol. 55, n° 8, p. 2911–2915. doi: 10.1002/anie.201511301
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN1433-7851
728views
3downloads

Technical informations

Creation16/02/2016 11:53:00
First validation16/02/2016 11:53:00
Update time15/03/2023 00:09:59
Status update15/03/2023 00:09:59
Last indexation31/10/2024 02:50:30
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack